Cellular and chemokine-mediated regulation in schistosome-induced hepatic pathology

Trends in Parasitology

Volumn 30, Issue 3, 2014, Pages 141-150

  Chuah, Candy ^a,b,c   Jones, Malcolm K ^a,b   Burke, Melissa L ^d   McManus, Donald P ^a   Gobert, Geoffrey N ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c SCHOOL OF MEDICAL SCIENCES   (Malaysia)

^d NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

Chemokine; Granuloma; Immunopathology; Schistosomiasis

Indexed keywords

CHEMOKINE; GRANULOMA; IMMUNOPATHOLOGY; SCHISTOSOMIASIS;

ANIMALS; CHEMOKINES; GRANULOMA; HUMANS; LIVER; SCHISTOSOMA; SCHISTOSOMA JAPONICUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SCHISTOSOMIASIS JAPONICA; SCHISTOSOMIASIS MANSONI;

EID: 84894324665     PISSN: 14714922     EISSN: 14715007     Source Type: Journal    
DOI: 10.1016/j.pt.2013.12.009     Document Type: Review

References (100)

1. Gryseels B., et al. Human schistosomiasis. Lancet 2006, 368:1106-1118.
2. Ross A.G., et al. Schistosomiasis. N. Engl. J. Med. 2002, 346:1212-1220.
3. McManus D.P., Loukas A. Current status of vaccines for schistosomiasis. Clin. Microbiol. Rev. 2008, 21:225-242.
4. Boros D.L. Immunopathology of Schistosoma mansoni infection. Clin. Microbiol. Rev. 1989, 2:250-269.
5. Almadi M.A., et al. New insights into gastrointestinal and hepatic granulomatous disorders. Nat. Rev. Gastroenterol. Hepatol. 2011, 8:455-466.
6. Wynn T.A., et al. Immunopathogenesis of schistosomiasis. Immunol. Rev. 2004, 201:156-167.
7. Chen M.G. Schistosoma japonicum and S. japonicum-like infections: epidemiology, clinical and pathological aspects. Human Schistosomiasis 1993, 237-270. CAB International. P. Jordan (Ed.).
8. Rollinson D. A wake up call for urinary schistosomiasis: reconciling research effort with public health importance. Parasitology 2009, 136:1593-1610.
9. Hsu S.Y., et al. Comparative studies on the lesions caused by eggs of Schistosoma japonicum and Schistosoma mansoni in livers of albino mice and rhesus monkeys. Ann. Trop. Med. Parasitol. 1972, 66:89-97.
10. Lenzi H.L., et al. Histoarchitecture of schistosomal granuloma development and involution: morphogenetic and biomechanical approaches. Mem. Inst. Oswaldo Cruz 1998, 93(Suppl. 1):141-151.
11. Lenzi H.L., et al. Four whole-istic aspects of schistosome granuloma biology: fractal arrangement, internal regulation, autopoietic component and closure. Mem. Inst. Oswaldo Cruz 2006, 101(Suppl. 1):219-231.
12. Burke M.L., et al. Immunopathogenesis of human schistosomiasis. Parasite Immunol. 2009, 31:163-176.
13. Pearce E.J., MacDonald A.S. The immunobiology of schistosomiasis. Nat. Rev. Immunol. 2002, 2:499-511.
14. Fallon P.G., et al. Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: IL-13 is a profibrotic agent. J. Immunol. 2000, 164:2585-2591.
15. Dewals B., et al. IL-4Ralpha responsiveness of non-CD4 T cells contributes to resistance in Schistosoma mansoni infection in pan-T cell-specific IL-4Ralpha-deficient mice. Am. J. Pathol. 2009, 175:706-716.
16. Truden J.L., Boros D.L. Collagenase, elastase, and nonspecific protease production by vigorous or immunomodulated liver granulomas and granuloma macrophages/eosinophils of S mansoni-infected mice. Am. J. Pathol. 1985, 121:166-175.
17. Chensue S.W., et al. Production of superoxide anion, prostaglandins, and hydroxyeicosatetraenoic acids by macrophages from hypersensitivity-type (Schistosoma mansoni egg) and foreign body-type granulomas. Infect. Immun. 1983, 42:1116-1125.
18. Stadecker M.J., et al. The immunobiology of Th1 polarization in high-pathology schistosomiasis. Immunol. Rev. 2004, 201:168-179.
19. Von Lichtenberg F., et al. Comparative histopathology of schistosome granulomas in the hamster. Am. J. Pathol. 1973, 72:149-178.
20. Weinstock J.V., Boros D.L. Organ-dependent differences in composition and function observed in hepatic and intestinal granulomas isolated from mice with schistosomiasis mansoni. J. Immunol. 1983, 130:418-422.
21. Hurst M.H., et al. Tissue responses in experimental schistosomiasis japonica in the pig: a histopathologic study of different stages of single low- or high-dose infections. Am. J. Trop. Med. Hyg. 2000, 62:45-56.
22. Wilson M.S., et al. Immunopathology of schistosomiasis. Immunol. Cell Biol. 2007, 85:148-154.
23. Wen X., et al. Dynamics of Th17 cells and their role in Schistosoma japonicum infection in C57BL/6 mice. PLoS Negl. Trop. Dis. 2011, 5:e1399.
24. Shainheit M.G., et al. The pathogenic Th17 cell response to major schistosome egg antigen is sequentially dependent on IL-23 and IL-1beta. J. Immunol. 2011, 187:5328-5335.
25. Rutitzky L.I., Stadecker M.J. CD4 T cells producing pro-inflammatory interleukin-17 mediate high pathology in schistosomiasis. Mem. Inst. Oswaldo Cruz 2006, 101(Suppl. 1):327-330.
26. Chen D., et al. Characteristics of IL-17 induction by Schistosoma japonicum infection in C57BL/6 mouse liver. Immunology 2013, 139:523-532.
27. Zhang Y., et al. IL-17 neutralization significantly ameliorates hepatic granulomatous inflammation and liver damage in Schistosoma japonicum infected mice. Eur. J. Immunol. 2012, 42:1523-1535.
28. Hurst M.H., et al. Experimental schistosomiasis japonica in the pig: immunohistology of the hepatic egg granuloma. Parasite Immunol. 2002, 24:151-159.
29. Ji F., et al. B cell response is required for granuloma formation in the early infection of Schistosoma japonicum. PLoS ONE 2008, 3:e1724.
30. Fairfax K.C., et al. IL-10R blockade during chronic schistosomiasis mansoni results in the loss of B cells from the liver and the development of severe pulmonary disease. PLoS Pathog. 2012, 8:e1002490.
31. Hesse M., et al. The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells. J. Immunol. 2004, 172:3157-3166.
32. + regulatory T cells are an essential, IL-10-independent part of the immunoregulatory network in Schistosoma mansoni egg-induced inflammation. J. Immunol. 2006, 176:5374-5387.
33. van der Vlugt L.E., et al. Schistosomes induce regulatory features in human and mouse CD1d(hi) B cells: inhibition of allergic inflammation by IL-10 and regulatory T cells. PLoS ONE 2012, 7:e30883.
34. Hoffmann K.F., et al. IL-10 and the dangers of immune polarization: excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis. J. Immunol. 2000, 164:6406-6416.
35. Taylor J.J., et al. Regulatory T cell responses develop in parallel to Th responses and control the magnitude and phenotype of the Th effector population. J. Immunol. 2006, 176:5839-5847.
36. Moore D.L., et al. The Schistosoma mansoni egg granuloma: quantitation of cell populations. J. Pathol. 1977, 121:41-50.
37. Behm C.A., Ovington K.S. The role of eosinophils in parasitic helminth infections: insights from genetically modified mice. Parasitol. Today 2000, 16:202-209.
38. Shin M.H., et al. Eosinophil-mediated tissue inflammatory responses in helminth infection. Korean J. Parasitol. 2009, 47(Suppl.):S125-S131.
39. Souza P.R., et al. The role of chemokines in controlling granulomatous inflammation in Schistosoma mansoni infection. Acta Trop. 2008, 108:135-138.
40. Falcao P.L., et al. Plasma concentrations and role of macrophage inflammatory protein-1alpha during chronic Schistosoma mansoni infection in humans. J. Infect. Dis. 2002, 186:1696-1700.
41. Sousa-Pereira S.R., et al. Serum and cerebral spinal fluid levels of chemokines and Th2 cytokines in Schistosoma mansoni myeloradiculopathy. Parasite Immunol. 2006, 28:473-478.
42. Souza A.L., et al. Potential role of the chemokine macrophage inflammatory protein 1alpha in human and experimental schistosomiasis. Infect. Immun. 2005, 73:2515-2523.
43. Lukacs N.W., et al. The role of macrophage inflammatory protein 1 alpha in Schistosoma mansoni egg-induced granulomatous inflammation. J. Exp. Med. 1993, 177:1551-1559.
44. Gao J.L., et al. Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1. J. Exp. Med. 1997, 185:1959-1968.
45. Silveira-Lemos D., et al. Seric chemokines and chemokine receptors in eosinophils during acute human schistosomiasis mansoni. Mem. Inst. Oswaldo Cruz 2010, 105:380-386.
46. Shang X.Z., et al. Eosinophil recruitment in type-2 hypersensitivity pulmonary granulomas: source and contribution of monocyte chemotactic protein-3 (CCL7). Am. J. Pathol. 2002, 161:257-266.
47. Jakubzick C., et al. Role of CCR4 ligands, CCL17 and CCL22, during Schistosoma mansoni egg-induced pulmonary granuloma formation in mice. Am. J. Pathol. 2004, 165:1211-1221.
48. Fu C.L., et al. A novel mouse model of Schistosoma haematobium egg-induced immunopathology. PLoS Pathog. 2012, 8:e1002605.
49. White J.R., et al. Cloning and functional characterization of a novel human CC chemokine that binds to the CCR3 receptor and activates human eosinophils. J. Leukoc. Biol. 1997, 62:667-675.
50. Chensue S.W., et al. Aberrant in vivo T helper type 2 cell response and impaired eosinophil recruitment in CC chemokine receptor 8 knockout mice. J. Exp. Med. 2001, 193:573-584.
51. Hu J.S., et al. AMD3465, a novel CXCR4 receptor antagonist, abrogates schistosomal antigen-elicited (type-2) pulmonary granuloma formation. Am. J. Pathol. 2006, 169:424-432.
52. Eriksson J., et al. The 434(G>C) polymorphism within the coding sequence of Eosinophil Cationic Protein (ECP) correlates with the natural course of Schistosoma mansoni infection. Int. J. Parasitol. 2007, 37:1359-1366.
53. Swartz J.M., et al. Schistosoma mansoni infection in eosinophil lineage-ablated mice. Blood 2006, 108:2420-2427.
54. de Andres B., et al. Lack of Fc-epsilon receptors on murine eosinophils: implications for the functional significance of elevated IgE and eosinophils in parasitic infections. Blood 1997, 89:3826-3836.
55. Seki T., et al. Interleukin-4 (IL-4) and IL-13 suppress excessive neutrophil infiltration and hepatocyte damage during acute murine schistosomiasis japonica. Infect. Immun. 2012, 80:159-168.
56. Smith P., et al. Schistosoma mansoni secretes a chemokine binding protein with antiinflammatory activity. J. Exp. Med. 2005, 202:1319-1325.
57. Schramm G., et al. IPSE/alpha-1: a major immunogenic component secreted from Schistosoma mansoni eggs. Mol. Biochem. Parasitol. 2006, 147:9-19.
58. Hirata M., et al. Neutropenia augments experimentally induced Schistosoma japonicum egg granuloma formation in CBA mice, but not in C57BL/6 mice. Parasite Immunol. 2002, 24:479-488.
59. Hirata M., Fukuma T. Cytokine regulation in experimentally-induced Schistosoma japonicum egg granuloma formation. Parasitol. Int. 2003, 52:341-349.
60. Burke M.L., et al. Temporal expression of chemokines dictates the hepatic inflammatory infiltrate in a murine model of schistosomiasis. PLoS Negl. Trop. Dis. 2010, 4:e598.
61. Perry C.R., et al. Differential expression of chemokine and matrix re-modelling genes is associated with contrasting schistosome-induced hepatopathology in murine models. PLoS Negl. Trop. Dis. 2011, 5:e1178.
62. Chuah C., et al. Spatial and temporal transcriptomics of Schistosoma japonicum-induced hepatic granuloma formation reveals novel roles for neutrophils. J. Leukoc. Biol. 2013, 94:353-365.
63. Brinkmann V., et al. Neutrophil extracellular traps kill bacteria. Science 2004, 303:1532-1535.
64. Urban C.F., et al. Neutrophil extracellular traps capture and kill Candida albicans yeast and hyphal forms. Cell. Microbiol. 2006, 8:668-676.
65. Guimaraes-Costa A.B., et al. Leishmania amazonensis promastigotes induce and are killed by neutrophil extracellular traps. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:6748-6753.
66. Saitoh T., et al. Neutrophil extracellular traps mediate a host defense response to human immunodeficiency virus-1. Cell Host Microbe 2012, 12:109-116.
67. Keshari R.S., et al. Neutrophil extracellular traps contain mitochondrial as well as nuclear DNA and exhibit inflammatory potential. Cytometry A 2012, 81:238-247.
68. Booth M., et al. Periportal fibrosis in human Schistosoma mansoni infection is associated with low IL-10, low IFN-gamma, high TNF-alpha, or low RANTES, depending on age and gender. J. Immunol. 2004, 172:1295-1303.
69. Friedman S.L. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008, 134:1655-1669.
70. Bartley P.B., et al. A contributory role for activated hepatic stellate cells in the dynamics of Schistosoma japonicum egg-induced fibrosis. Int. J. Parasitol. 2006, 36:993-1001.
71. Chang D., et al. Hepatic stellate cells in human schistosomiasis mansoni: a comparative immunohistochemical study with liver cirrhosis. Acta Trop. 2006, 97:318-323.
72. Anthony B.J., et al. Role of resident liver cells in the pathogenesis of schistosomiasis. Trends Parasitol. 2012, 28:572-579.
73. Anthony B., et al. Schistosoma mansoni: egg-induced downregulation of hepatic stellate cell activation and fibrogenesis. Exp. Parasitol. 2010, 124:409-420.
74. Anthony B.J., et al. Schistosoma eggs induce a proinflammatory, anti-fibrogenic phenotype in hepatic stellate Cells. PLoS ONE 2013, 8:e68479.
75. Ramm G.A. Chemokine (C-C motif) receptors in fibrogenesis and hepatic regeneration following acute and chronic liver disease. Hepatology 2009, 50:1664-1668.
76. Ramm G.A. Anti-chemokine therapy for the treatment of hepatic fibrosis: an attractive approach. Hepatology 2011, 54:354-358.
77. Saiman Y., Friedman S.L. The role of chemokines in acute liver injury. Front. Physiol. 2012, 3:213.
78. Karlmark K.R., et al. Chemokine-directed immune cell infiltration in acute and chronic liver disease. Expert Rev. Gastroenterol. Hepatol. 2008, 2:233-242.
79. Seki E., et al. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat. Med. 2007, 13:1324-1332.
80. Ramm G.A., et al. Fibrogenesis in pediatric cholestatic liver disease: role of taurocholate and hepatocyte-derived monocyte chemotaxis protein-1 in hepatic stellate cell recruitment. Hepatology 2009, 49:533-544.
81. Liang Y.J., et al. Gene profile of chemokines on hepatic stellate cells of schistosome-infected mice and antifibrotic roles of CXCL9/10 on liver non-parenchymal cells. PLoS ONE 2012, 7:e42490.
82. Gordon S. Alternative activation of macrophages. Nat. Rev. Immunol. 2003, 3:23-35.
83. Hesse M., et al. Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism. J. Immunol. 2001, 167:6533-6544.
84. Ragheb S., Boros D.L. Characterization of granuloma T lymphocyte function from Schistosoma mansoni-infected mice. J. Immunol. 1989, 142:3239-3246.
85. Warmington K.S., et al. Effect of C-C chemokine receptor 2 (CCR2) knockout on type-2 (schistosomal antigen-elicited) pulmonary granuloma formation: analysis of cellular recruitment and cytokine responses. Am. J. Pathol. 1999, 154:1407-1416.
86. Sandler N.G., et al. Global gene expression profiles during acute pathogen-induced pulmonary inflammation reveal divergent roles for Th1 and Th2 responses in tissue repair. J. Immunol. 2003, 171:3655-3667.
87. Anthony B.J., et al. A role for peroxisome proliferator-activated receptors in the immunopathology of schistosomiasis?. PPAR Res. 2012, 2012:128068.
88. Cheng P.C., et al. A study of immunomodulatory genes responses to macrophages of Schistosoma japonicum infection during different stages by microarray analysis. Acta Trop. 2013, 127:251-260.
89. Bronte V., et al. L-arginine metabolism in myeloid cells controls T-lymphocyte functions. Trends Immunol. 2003, 24:302-306.
90. Pesce J.T., et al. Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis. PLoS Pathog. 2009, 5:e1000371.
91. Wang W., et al. Enhanced expression of the decoy receptor IL-13Ralpha2 in macrophages of Schistosoma japonicum-infected mice. Chin. Med. J. (Engl.) 2009, 122:1650-1654.
92. Mentink-Kane M.M., et al. IL-13 receptor alpha 2 down-modulates granulomatous inflammation and prolongs host survival in schistosomiasis. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:586-590.
93. Wynn T.A., Barron L. Macrophages: master regulators of inflammation and fibrosis. Semin. Liver Dis. 2010, 30:245-257.
94. Duffield J.S., et al. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J. Clin. Invest. 2005, 115:56-65.
95. Fallowfield J.A., et al. Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis. J. Immunol. 2007, 178:5288-5295.
96. Ramachandran P., Iredale J.P. Macrophages: central regulators of hepatic fibrogenesis and fibrosis resolution. J. Hepatol. 2012, 56:1417-1419.
97. Harty M.W., et al. Hepatic macrophages promote the neutrophil-dependent resolution of fibrosis in repairing cholestatic rat livers. Surgery 2008, 143:667-678.
98. Li H., et al. Highly up-regulated CXCR3 expression on eosinophils in mice infected with Schistosoma japonicum. Immunology 2004, 111:107-117.
99. Warren K.S., Domingo E.O. Granuloma formation around Schistosoma mansoni, S. haematobium, and S. japonicum eggs. Size and rate of development, cellular composition, cross-sensitivity, and rate of egg destruction. Am. J. Trop. Med. Hyg. 1970, 19:292-304.
100. Young N.D., et al. Whole-genome sequence of Schistosoma haematobium. Nat. Genet. 2012, 44:221-225.